Diagnostic ultrasound ( PDFDrive )

CHAPTER 10 The Prostate and Transrectal Ultrasound 415
141. Salomon G, Schifmann J. Real-time elastography for the detection of prostate
cancer. Curr Urol Rep. 2014;15(3):392.
142. Scattoni V, Maccagnano C, Capitanio U, et al. Random biopsy: when, how
many and where to take the cores? World J Urol. 2014;32(4):859-869.
143. Ukimura O, Coleman JA, de la Taille A, et al. Contemporary role of systematic
prostate biopsies: indications, techniques, and implications for patient care.
Eur Urol. 2013;63(2):214-230.
144. Nishimura RA, Carabello BA, Faxon DP, et al. ACC/AHA 2008 guideline
update on valvular heart disease: focused update on infective endocarditis:
a report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines endorsed by the Society of Cardiovascular
Anesthesiologists, Society for Cardiovascular Angiography and Interventions,
and Society of horacic Surgeons. J Am Coll Cardiol. 2008;52(8):
676-685.
145. Chang DT, Challacombe B, Lawrentschuk N. Transperineal biopsy of the
prostate—is this the future? Nat Rev Urol. 2013;10(12):690-702.
146. Averch T, Tessier T, Clemens JC, Franks M. AUA Quality Improvement
Summit 2014: Conference proceedings on infectious complications of
transrectal needle biopsy. AUA; 2014. Cited 4 June 2016. Available from:
https://www.auanet.org/common/pdf/practices-resources/quality/whitepapers/QI-Summit.pdf.
147. Cussans A, Somani BK, Basarab A, Dudderidge TJ. he role of targeted
prophylactic antimicrobial therapy before transrectal ultrasonography-guided
prostate biopsy in reducing infection rates: a systematic review. BJU Int.
2016;117(5):725-731.
148. Liss MA, Ehdie B, Loeb S, Meng MV. AUA White Paper: he prevention
and treatment of the more common complications related to prostate biopsy
update. AUA; 2016. Updated 2016; cited 4 June 2016. Available from: https://
www.auanet.org/common/pdf/education/clinical-guidance/AUA-PNB-
White-Paper.pdf.
149. Lee C, Woo HH. Current methods of analgesia for transrectal ultrasonography
(TRUS)–guided prostate biopsy—a systematic review. BJU Int. 2014;113(Suppl.
2):48-56.
150. Nazir B. Pain during transrectal ultrasound-guided prostate biopsy and the
role of periprostatic nerve block: what radiologists should know. Korean J
Radiol. 2014;15(5):543-553.
151. Culkin DJ, Exaire EJ, Green D, et al. Anticoagulation and antiplatelet therapy
in urological practice: ICUD/AUA review paper. J Urol. 2014;192(4):1026-
1034.
152. Patel IJ, Davidson JC, Nikolic B, et al. Addendum of newer anticoagulants
to the SIR consensus guideline. J Vasc Interv Radiol. 2013;24(5):
641-645.
153. Taneja SS, Bjurlin MA, Carter B, Cookson MS. AUA White Paper: Optimal
techniques of prostate biopsy and specimen handling. AUA; 2015. Updated
2015; cited 4 June 2016. [AUA guideline for biopsy]. Available from:
www.White Paper: AUA/Optimal Techniques of Prostate Biopsy and Specimen
Handling.pdf.
154. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus
directed ultrasound guided transrectal core biopsies of the prostate. J Urol.
1989;142(1):71-74.
155. Neill MG, Toi A, Lockwood GA, et al. Systematic lateral prostate biopsy—are
the beneits worth the costs? J Urol. 2008;179(4):1321-1326.
156. Kim CK. Magnetic resonance imaging-guided prostate biopsy: present and
future. Korean J Radiol. 2015;16(1):90-98.
157. Murphy G, Haider M, Ghai S, Sreeharsha B. he expanding role of MRI
in prostate cancer. AJR Am J Roentgenol. 2013;201(6):1229-1238.
158. Pokorny MR, de Rooij M, Duncan E, et al. Prospective study of diagnostic
accuracy comparing prostate cancer detection by transrectal ultrasoundguided
biopsy versus magnetic resonance (MR) imaging with subsequent
MR-guided biopsy in men without previous prostate biopsies. Eur Urol.
2014;66(1):22-29.
159. Schoots IG, Roobol MJ, Nieboer D, et al. Magnetic resonance imaging–
targeted biopsy may enhance the diagnostic accuracy of signiicant prostate
cancer detection compared to standard transrectal ultrasound-guided biopsy:
a systematic review and meta-analysis. Eur Urol. 2015;68(3):438-450.
160. Rosenkrantz AB, Taneja SS. Prostate MRI and MRI-targeted biopsy in
patients with prior negative biopsy. AUA and SAR joint consensus statement:
AUA, SAR; 2016. Cited 4 June 2016. Available from: https://www.auanet.org/
common/pdf/education/clinical-guidance/Consensus-Statement-Prostate-
MRI-and-MRI-Targeted-Biopsy.pdf.
161. Gayet M, van der Aa A, Beerlage HP, et al. he value of magnetic resonance
imaging and ultrasonography (MRI/US)–fusion biopsy platforms in prostate
cancer detection: a systematic review. BJU Int. 2016;117(3):392-400.
162. Valerio M, Donaldson I, Emberton M, et al. Detection of clinically signiicant
prostate cancer using magnetic resonance imaging–ultrasound fusion targeted
biopsy: a systematic review. Eur Urol. 2015;68(1):8-19.
163. Costa DN, Pedrosa I, Donato Jr F, et al. MR imaging–transrectal US fusion
for targeted prostate biopsies: implications for diagnosis and clinical
management. Radiographics. 2015;35(3):696-708.
164. Stephenson SK, Chang EK, Marks LS. Screening and detection advances
in magnetic resonance image–guided prostate biopsy. Urol Clin North Am.
2014;41(2):315-326.
165. Logan JK, Rais-Bahrami S, Turkbey B, et al. Current status of magnetic
resonance imaging (MRI) and ultrasonography fusion sotware platforms
for guidance of prostate biopsies. BJU Int. 2014;114(5):641-652.
166. Sivaraman A, Sanchez-Salas R, Barret E, et al. Transperineal template-guided
mapping biopsy of the prostate. Int J Urol. 2015;22(2):146-151.
167. Shinohara K, Gulati M, Koppie T, Terris MK. Transperineal prostate biopsy
ater abdominoperineal resection. J Urol. 2003;169(1):141-144.